There were 160 press releases posted in the last 24 hours and 357,373 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image